SenesTech to Participate at Lytham Partners Spring 2023 Investor Conference on May 18, 2023
PHOENIX, May 15, 2023 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced Joel Fruendt, CEO, will participate in a fireside chat and host one-on-one meetings with investors at the Lytham Partners Spring 2023 Investor Conference, taking … Read more